human il 1α elisa duo set (R&D Systems)
R&D Systems is a verified supplier 
R&D Systems manufactures this product 
94
Structured Review
R&D Systems
human il 1α elisa duo set
Human Il 1α Elisa Duo Set, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 77 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+il+1%CE%B1+elisa+duo+set/Human+IL-1+alpha%2FIL-1F1+DuoSet+ELISA/us11135241-200-15-20
Average 94 stars, based on 77 article reviews
Human Il 1α Elisa Duo Set, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 77 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+il+1%CE%B1+elisa+duo+set/Human+IL-1+alpha%2FIL-1F1+DuoSet+ELISA/us11135241-200-15-20
Average 94 stars, based on 77 article reviews
human il 1α elisa duo set - by Bioz Stars,
2026-09
94/100 stars
Images
Related Articles
Concentration Assay:Article Title: Compositions and methods to affect skin irritation Article Snippet: .. Media was collected at 96 hour post treatment and IL-1α concentration was analyzed using the Article Title: Compositions and methods to affect skin irritation Article Snippet: .. Media was collected at 96 hour post treatment and IL-1α concentration was analyzed using the Article Title: Compositions and methods to affect skin irritation Article Snippet: .. Media was collected at 96 hour post treatment and IL-1α concentration was analyzed using the Enzyme-linked Immunosorbent Assay:Article Title: Compositions and methods to affect skin irritation Article Snippet: .. Media was collected at 96 hour post treatment and IL-1α concentration was analyzed using the Article Title: Compositions and methods to affect skin irritation Article Snippet: .. IL-1α secretion was analyzed using the Article Title: Compositions and methods to affect skin irritation Article Snippet: .. IL-1α secretion was analyzed using the Article Title: Compositions and methods to affect skin irritation Article Snippet: .. Media was collected at 96 hour post treatment and IL-1α concentration was analyzed using the Article Title: Compositions and methods to affect skin irritation Article Snippet: .. IL-1α secretion was analyzed using the Article Title: Compositions and methods to affect skin irritation Article Snippet: .. TABLE 1 Tissue viability assay upon SDS exposure mean of SD viability [%] of viability NC (PBS) 100.0 10.28 PC (5% SDS) 11.1 0.87 0.2% SDS 110.0 4.00 0.4% SDS 106.3 4.76 0.6% SDS 13.8 4.51 1% OsC 105.3 4.61 0.2% SDS + 1% modified chitosan 110.5 0.82 0.4% SDS + 1% modified chitosan 104.4 1.53 0.6% SDS + 1% modified chitosan 109.8 4.75 IL-1α secretion was analyzed using the Article Title: Compositions and methods to affect skin irritation Article Snippet: .. Media was collected at 96 hour post treatment and IL-1α concentration was analyzed using the Article Title: Compositions and methods to affect skin irritation Article Snippet: .. TABLE 1 Tissue viability assay upon SDS exposure mean of SD of viability % viability NC (PBS) 100.0 10.28 PC (5% SDS) 11.1 0.87 0.2% SDS 110.0 4.00 0.4% SDS 106.3 4.76 0.6% SDS 13.8 4.51 1% OsC 105.3 4.61 0.2%SDS + 1% modified chitosan 110.5 0.82 0.4%SDS + 1% modified chitosan 104.4 1.53 0.6%SDS + 1% modified chitosan 109.8 4.75 IL-1α secretion was analyzed using the Viability Assay:Article Title: Compositions and methods to affect skin irritation Article Snippet: .. TABLE 1 Tissue viability assay upon SDS exposure mean of SD viability [%] of viability NC (PBS) 100.0 10.28 PC (5% SDS) 11.1 0.87 0.2% SDS 110.0 4.00 0.4% SDS 106.3 4.76 0.6% SDS 13.8 4.51 1% OsC 105.3 4.61 0.2% SDS + 1% modified chitosan 110.5 0.82 0.4% SDS + 1% modified chitosan 104.4 1.53 0.6% SDS + 1% modified chitosan 109.8 4.75 IL-1α secretion was analyzed using the Article Title: Compositions and methods to affect skin irritation Article Snippet: .. TABLE 1 Tissue viability assay upon SDS exposure mean of SD of viability % viability NC (PBS) 100.0 10.28 PC (5% SDS) 11.1 0.87 0.2% SDS 110.0 4.00 0.4% SDS 106.3 4.76 0.6% SDS 13.8 4.51 1% OsC 105.3 4.61 0.2%SDS + 1% modified chitosan 110.5 0.82 0.4%SDS + 1% modified chitosan 104.4 1.53 0.6%SDS + 1% modified chitosan 109.8 4.75 IL-1α secretion was analyzed using the Modification:Article Title: Compositions and methods to affect skin irritation Article Snippet: .. TABLE 1 Tissue viability assay upon SDS exposure mean of SD viability [%] of viability NC (PBS) 100.0 10.28 PC (5% SDS) 11.1 0.87 0.2% SDS 110.0 4.00 0.4% SDS 106.3 4.76 0.6% SDS 13.8 4.51 1% OsC 105.3 4.61 0.2% SDS + 1% modified chitosan 110.5 0.82 0.4% SDS + 1% modified chitosan 104.4 1.53 0.6% SDS + 1% modified chitosan 109.8 4.75 IL-1α secretion was analyzed using the Article Title: Compositions and methods to affect skin irritation Article Snippet: .. TABLE 1 Tissue viability assay upon SDS exposure mean of SD of viability % viability NC (PBS) 100.0 10.28 PC (5% SDS) 11.1 0.87 0.2% SDS 110.0 4.00 0.4% SDS 106.3 4.76 0.6% SDS 13.8 4.51 1% OsC 105.3 4.61 0.2%SDS + 1% modified chitosan 110.5 0.82 0.4%SDS + 1% modified chitosan 104.4 1.53 0.6%SDS + 1% modified chitosan 109.8 4.75 IL-1α secretion was analyzed using the |